Attention deficit-hyperactivity disorder: Current findings and treatment

Current Opinion in Psychiatry

Volumn 14, Issue 4, 2001, Pages 309-316

  Rubia, Katya ^a   Smith, Anna ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CHILD; COMORBIDITY; DIAGNOSTIC IMAGING; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC PREDISPOSITION; HEREDITY; HUMAN; HYPERACTIVITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOSIS; REVIEW; STRUCTURE ACTIVITY RELATION; TERATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034920470     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200107000-00013     Document Type: Review

References (111)

1. The dynamic approach to neurodevelopmental psychiatric disorders: Use of fMRI combined with neuropsychology to elucidate the dynamics of psychiatric disorders, exemplified in ADHD and schizophrenia
2. Attention deficit-hyperactivity disorder: Biological causes and treatments
3. Attention deficit hyperactivity disorder: Current progress and controversies
4. Disentangling the overlap between Tourette's disorder and ADHD
5. Attention deficit hyperactivity disorder and anxiety: Is there an association with neurodevelopmental deficits?
6. Bipolar disorder and attention-deficit/hyperactivity disorder in children and adolescents
7. Quantitative and qualitative aspects of obsessive-compulsive behaviour in children with attention-deficit hyperactivity disorder compared with tic disorder
8. Attention deficit hyperactivity disorder and affective disorders in childhood: Continuum, comorbidity or confusion
9. Familial aggregation of emotional and behavioral-problems of childhood in the general-population
10. Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins
11. Attention-deficit disorder and conduct disorder in girls: Evidence for a familial subtype
12. A pilot family study of childhood-onset mania
13. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder
14. Attention-deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity?
15. Attention deficit hyperactivity disorder with bipolar disorder: A familial subtype?
16. Aggressive behaviour in children with Tourette syndrome and comorbid attention-deficit hyperactivity disorder and obsessive-compulsive disorder
17. Inhibitory deficits in Tourette syndrome: A function of comorbidity and symptom severity
18. Multiple sources of attentional dysfunction in adults with Tourette's syndrome: Comparison with attention deficit-hyperactivity disorder
19. Differential measures of "sustained attention" in children with attention-deficit/hyperactivity or tic diorders: Relations to monoamine metabolism
20. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder
21. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders
22. Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments
23. Preliminary finding of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders
24. Not in their genes: A critical view of the genetics of attention deficit hyperactivity disorder
25. Nature, nurture and attention deficit hyperactivity disorder
26. Family study of girls with attention deficit hyperactivity disorder
27. The equal environment assumption of the classical twin method: A critical analysis
28. Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder
29. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviours: Tourette syndrome, ADHD, pathological gambling, and substance abuse
30. Dopamine D-4 gene 7-repeat allele and attention deficit hyperactivity disorder
31. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
32. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder
33. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder
34. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach
35. Association study of DSM-IV attention deficit hyperactivity disorder (ADHD) and monoamine pathway genes
36. Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: Genetic and brain morphometric analyses
37. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
38. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD)
39. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population
40. Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene: Evidence of association but no linkage in a UK sample
41. Association of attention deficit disorder and the dopamine transporter gene
42. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity
43. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
44. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
45. Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors
46. Dopamine transporter density in patients with attention deficit hyperactivity disorder
47. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
48. Age-related changes in brain glucose metabolism in adults with attention-deficit/hyperactivity disorder and control subjects
49. Dopamine-transporter density in patients with ADHD
50. FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa
51. Relationship between impulsivity and platelet serotonin content in adolescents
52. Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample
53. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity
54. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder
55. Volumetric MRI analysis comparing attention-deficit hyperactivity disorder and normal controls
56. The cerebellum in attention-deficit/hyperactivity disorder: A morphometric study
57. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomic abnormality in an attentional network
58. Hypofrontality in attention deficit hyperactivity disorder during higher order motor control: A study with fMRI
59. A possible pathophysiologic substrate of attention deficit hyperactivity disorder
60. Neuropsychological analyses of impulsiveness in childhood hyperactivity
61. Effects of stimulant medication on the lateralisation of line bisection judgements of children with attention deficit hyperactivity disorder
62. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder
63. Inhibitory control in children with attention-deficit/hyperactivity disorder: Event-related potentials identify the processing component and timing of an impaired right-frontal response inhibition mechanism
64. Atypical frontal brain activation in ADHD: Preschool and elementary school boys and girls
65. Frontalisation with age: Mapping neurodevelopmental trajectories with fMRI
66. Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity
67. Functional deficits in basal ganglia of children with attention deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry
68. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals
69. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study
70. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder
71. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus
72. Effects of methylphenidate on functional MRI blood-oxygen-level-dependent contrast
73. Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder
74. Age-related changes in quantitative EEG in attention-deficit/hyperactivity disorder
75. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type
76. Dramatic increase in methylphenidate consumption
77. Methylphenidate and brain dopamine neurotoxicity
78. Quantitative morphology of the caudate and putamen in patients with cocaine dependence
79. Higher cortical and lower subcortical metabolism in detoxified metamphetamine abusers
80. Psychotic side effects of psychostimulants: A 5-year review
81. Attention-deficit hyperactivity disorder in children and youth: A quantatative systematic review of the efficacy of different management strategies
82. Parental knowledge of attention-deficit hyperactivity disorder and opinions of treatment options: Impact on enrolment and adherence to a 12 month treatment trial
83. The NIMH Multimodal Treatment Study for Attention-Deficit Hyperactivity Disorder
84. In the wake of the MTA: Charting a new course for the study and treatment of children with attention-deficit hyperactivity disorder
85. Abnormal motor cortex organization contralateral to early upper limb amputation in humans
86. Motor-learning-related changes in piano players and non-musicians revealed by functional magnetic-resonance signals
87. Increased auditory cortical representation in musicians
88. Magnetoencephalographic studies of functional organization and plasticity of the human auditory cortex
89. Family environment in attention deficit hyperactivity, oppositional defiant and conduct disorders
90. Child and adolescent psychopathology research: Problems and prospects for the 1990s
91. Family-environment risk factors for attention-deficit hyperactivity disorder
92. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder
93. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder - The multimodal treatment study of children with attention-deficit/hyperactivity disorder
94. Appropriateness of psychostimulant prescription to children. Theoretical and empirical perspectives
95. Stimulant treatment for children: A community perspective
96. Development of clinical services for attention deficit/hyperactivity disorder
97. Prescribing practices of Ritalin: The Suffolk County, New York study
98. Behavioral and pharmacological treatment of hyperactivity and attention-deficit disorders
99. Vicissitudes of follow-up studies: Differential effects of parent training and stimulant medication with hyperactives
100. Behavior therapy and methylphenidate in the treatment of children with ADHD
101. The combination of behavior therapy and methyphenidate in the treatment of hyperactivity: A therapy outcome study
102. Lessons from large trails: The MTA study as a model for evaluating the treatment of childhood psychiatric disorder
103. Fact versus fancy concerning the multimodal treatment study for attention-deficit hyperactivity disorder
104. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: Main and incremental effects across settings
105. Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with ADHD
106. What the multimodal treatment study of children with attention deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits
107. Dextroamphetamine. Cognitive and behavioral effects in normal prepubertal boys
108. Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and men
109. Caffeine effects on learning, performance, and anxiety in normal school-age children